PensionBee Group Valuation
Is PBEEL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PBEEL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate PBEEL's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate PBEEL's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PBEEL?
Key metric: As PBEEL is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is PBEEL's PS Ratio? | |
---|---|
PS Ratio | 12.5x |
Sales | UK£28.32m |
Market Cap | UK£355.26m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 12.2x |
Enterprise Value/EBITDA | -69.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does PBEEL's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 4.2x | ||
GHE Gresham House | 5.2x | 9.4% | UK£444.6m |
POLN Pollen Street Group | 4x | 6.2% | UK£438.6m |
BPM B.P. Marsh & Partners | 4x | n/a | UK£263.1m |
FSG Foresight Group Holdings | 3.6x | 10.6% | UK£506.2m |
PBEEL PensionBee Group | 12.5x | 20.7% | UK£355.3m |
Price-To-Sales vs Peers: PBEEL is expensive based on its Price-To-Sales Ratio (12.5x) compared to the peer average (4.3x).
Price to Sales Ratio vs Industry
How does PBEEL's PS Ratio compare vs other companies in the GB Capital Markets Industry?
Price-To-Sales vs Industry: PBEEL is expensive based on its Price-To-Sales Ratio (12.5x) compared to the UK Capital Markets industry average (3.2x).
Price to Sales Ratio vs Fair Ratio
What is PBEEL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 12.5x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate PBEEL's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | UK£1.51 | UK£2.01 +33.2% | 10.4% | UK£2.18 | UK£1.65 | n/a | 4 |
Nov ’25 | UK£1.64 | UK£2.01 +22.4% | 10.4% | UK£2.18 | UK£1.65 | n/a | 4 |
Oct ’25 | UK£1.76 | UK£1.94 +10.5% | 9.7% | UK£2.11 | UK£1.65 | n/a | 4 |
Sep ’25 | UK£1.75 | UK£1.94 +10.9% | 9.7% | UK£2.11 | UK£1.65 | n/a | 4 |
Aug ’25 | UK£1.65 | UK£1.94 +17.9% | 9.7% | UK£2.11 | UK£1.65 | n/a | 4 |
Jul ’25 | UK£1.66 | UK£1.58 -4.8% | 12.2% | UK£1.72 | UK£1.25 | n/a | 4 |
Jun ’25 | UK£1.48 | UK£1.58 +7.1% | 12.2% | UK£1.72 | UK£1.25 | n/a | 4 |
May ’25 | n/a | UK£1.58 0% | 12.2% | UK£1.72 | UK£1.25 | n/a | 4 |
Apr ’25 | n/a | UK£1.42 0% | 18.8% | UK£1.70 | UK£1.07 | n/a | 4 |
Mar ’25 | n/a | UK£1.42 0% | 18.8% | UK£1.70 | UK£1.07 | n/a | 4 |
Feb ’25 | n/a | UK£1.45 0% | 15.6% | UK£1.70 | UK£1.20 | n/a | 4 |
Jan ’25 | n/a | UK£1.45 0% | 15.6% | UK£1.70 | UK£1.20 | n/a | 4 |
Dec ’24 | n/a | UK£1.45 0% | 15.6% | UK£1.70 | UK£1.20 | n/a | 4 |
Nov ’24 | n/a | UK£1.45 0% | 15.6% | UK£1.70 | UK£1.20 | UK£1.64 | 4 |
Oct ’24 | n/a | UK£1.49 0% | 17.8% | UK£1.80 | UK£1.20 | UK£1.76 | 4 |
Sep ’24 | n/a | UK£1.49 0% | 17.8% | UK£1.80 | UK£1.20 | UK£1.75 | 4 |
Aug ’24 | n/a | UK£1.49 0% | 17.8% | UK£1.80 | UK£1.20 | UK£1.65 | 4 |
Jul ’24 | n/a | UK£1.49 0% | 17.8% | UK£1.80 | UK£1.20 | UK£1.66 | 4 |
Jun ’24 | n/a | UK£1.65 0% | 24.4% | UK£2.30 | UK£1.20 | UK£1.48 | 5 |
May ’24 | n/a | UK£1.65 0% | 24.4% | UK£2.30 | UK£1.20 | n/a | 5 |
Apr ’24 | n/a | UK£1.59 0% | 32.1% | UK£2.30 | UK£0.75 | n/a | 5 |
Mar ’24 | n/a | UK£1.57 0% | 32.8% | UK£2.17 | UK£0.75 | n/a | 4 |
Feb ’24 | n/a | UK£1.57 0% | 32.8% | UK£2.17 | UK£0.75 | n/a | 4 |
Jan ’24 | n/a | UK£1.60 0% | 7.3% | UK£1.70 | UK£1.40 | n/a | 4 |
Dec ’23 | n/a | UK£1.60 0% | 7.3% | UK£1.70 | UK£1.40 | n/a | 4 |
Nov ’23 | n/a | UK£1.71 0% | 14.7% | UK£2.10 | UK£1.40 | n/a | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
ASA International Group
UK£65.0m
Provides microfinancing services in Africa and Asia.
ASAI
UK£0.65
7D
0.8%
1Y
28.5%
Exor
€20.2b
Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.
0RKY
€94.25
7D
0.6%
1Y
8.0%
Man Group
UK£2.4b
Man Group Limited is a publicly owned investment manager.
EMGL
UK£2.06
7D
-0.6%
1Y
-0.7%